About Heer Pharma Private Limited
Data last updated:
Heer Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 22 June 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51900MH1993PTC072516. Its GSTIN is 27AAACH8217P1Z5 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.1 Lakh. It was formerly known as Heer Trade-Chem Private Limited. It is led by directors including Prashant Kirit Shah (Managing Director) and Beejal Prashant Shah (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹52 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹1.17 Cr (net margin 2.3%) and EBITDA of ₹1.63 Cr (EBITDA margin 3.1%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 16% over five years.
The company is associated with 1 brand: Heer Pharma. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 2 cases are pending. The company has 1 deal on record (1 secondary share transfer); the latest was in March 2015. Its 4 peer companies in the Pharma industry (Animal Pharma), with the same principal business activity (wholesale trading) are compared by revenue, 1 larger and 3 smaller; the largest is Wellcon Animal Health Private Limited with revenue of ₹53.42 Cr. The company has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 3 overdue payments to 3 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website heerpharma.com.
Company details
Contact details
Heer Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is heerpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit No 317 Unique Industrial Estate 3rd Floor Off V S Marg Twin Tower Lane Prabhadev, I, Mumbai, Maharashtra, India – 400025
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Heer Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Heer Pharma operates one associated brand: Heer Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and exports APIs, veterinary drugs, and excipients for global markets. | heerpharma.com |
Business activity
The main business activity of Heer Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Heer Pharma Private Limited, buy the company report.
Financials of Heer Pharma Private Limited
FY 2025 filings availableHeer Pharma Private Limited reported revenue of ₹52 Cr (down 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 16%. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹52 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.63 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.17 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Heer Pharma Private Limited, buy the company report.
Board of directors of Heer Pharma Private Limited
Heer Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mrudula Kirit Shah | Director | 22 Jun 1993 | 33 Years 4 Months | Current |
| Prashant Kirit Shah Also directs: Neha Pharma Pvt Ltd | Managing Director | 04 Apr 1995 | 31 Years 6 Months | Current |
| Beejal Prashant Shah | Whole-Time Director | 03 Apr 2006 | 20 Years 6 Months | Current |
Peer comparison
Heer Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Animal Pharma), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wellcon Animal Health Private Limited | ₹53.42 Cr (FY 2025) | 15.0% | Agra, Uttar Pradesh, India | |||
| Heer Pharma Private Limitedthis company | ₹52 Cr (FY 2024) | ₹1.17 Cr | 2.3% | -4.0% | Mumbai, Maharashtra, India | |
| Dosch Pharmaceuticals Pvt Ltd | ₹49.93 Cr (FY 2019) | 23.0% | Mumbai, Maharashtra, India | |||
| Nutrivet Farm Care Private Limited | ₹49.27 Cr (FY 2025) | -7.0% | Patna, Bihar, India | |||
| PP & B Mart Private Limited | ₹44.58 Cr (FY 2025) | 9.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Heer Pharma Private Limited, buy the company report.
Auditor
Heer Pharma Private Limited is audited by Rasik R. Thakkar for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rasik R. Thakkar | FY 2024 | 015924 |
Shareholding
The shareholding of Heer Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Heer Pharma Private Limited, buy the company report.
Deals & funding
Heer Pharma Private Limited has 1 deal on record (1 secondary share transfer); the latest was in March 2015.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Heer Pharma Private Limited has 4 court cases on record: 3 filed by Heer Pharma, 1 filed against it. 2 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 1 | 2 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Ss cases s) | Filed by the company against Chandrakant Gupta Owner of Ashutosh Chemicals | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons warrent Cases SW) | Filed against the company by an individual | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Ss cases s) | Filed by the company against M-S Dinesh Pharmaceuticals P Ltd. | Disposed |
To see the full case history of Heer Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Heer Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 3 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Siflon Drugs | |||
| Apex Healthcare Limited | |||
| Ascent Pharma |
To see the full MSME payment records of Heer Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Heer Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACH8217P1Z5 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Heer Pharma Private Limited, buy the company report.
Recent activity
Heer Pharma Private Limited has 3 board changes on record since 1993: 3 appointments. The latest: Beejal Prashant Shah was appointed as Whole-Time Director on 03 Apr 2006.
Frequently asked questions
Heer Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 22 June 1993 (33+ years old) and is registered under CIN U51900MH1993PTC072516.
Heer Pharma has 3 current directors:
- Prashant Kirit Shah - Managing Director
- Beejal Prashant Shah - Whole-Time Director
- Mrudula Kirit Shah - Director
The latest financial statements of Heer Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Heer Pharma is 27AAACH8217P1Z5, registered in Maharashtra.
The CIN (Corporate Identification Number) of Heer Pharma is U51900MH1993PTC072516. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Heer Pharma has 4 court cases on record: 3 filed by the company and 1 filed against it. 2 are pending.
Heer Pharma was incorporated on 22 June 1993, making it 33+ years old. It is registered with the Registrar of Companies, Mumbai.
Heer Pharma has 1 deal on record (1 secondary share transfer); the latest was in March 2015.
The peers of Heer Pharma by revenue are Wellcon Animal Health Private Limited, Dosch Pharmaceuticals Pvt Ltd, Nutrivet Farm Care Private Limited, PP & B Mart Private Limited, all in the Pharma industry (Animal Pharma), with the same principal business activity (wholesale trading).
Beejal Prashant Shah was appointed as Whole-Time Director on 03 Apr 2006. Prashant Kirit Shah was appointed as Managing Director on 04 Apr 1995. Mrudula Kirit Shah was appointed as Director on 22 Jun 1993.
Heer Pharma has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 3 overdue payments to 3 micro and small suppliers. The latest return was filed on 07 Jun 2019.
Heer Pharma can be reached through the website heerpharma.com. Its registered office is in Mumbai, Maharashtra, India.